These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16362939)

  • 1. The BeLPT: algorithms and implications.
    Middleton DC; Lewin MD; Kowalski PJ; Cox SS; Kleinbaum D
    Am J Ind Med; 2006 Jan; 49(1):36-44. PubMed ID: 16362939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing BeLPT criteria for beryllium sensitization.
    Middleton DC; Fink J; Kowalski PJ; Lewin MD; Sinks T
    Am J Ind Med; 2008 Mar; 51(3):166-72. PubMed ID: 18181198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity.
    Milovanova TN
    Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
    Stange AW; Furman FJ; Hilmas DE
    Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the blood beryllium lymphocyte proliferation test.
    Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):953-6. PubMed ID: 8933041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test.
    Amicosante M; Deubner D; Saltini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):175-9. PubMed ID: 16315779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beryllium health effects in the era of the beryllium lymphocyte proliferation test.
    Maier LA
    Appl Occup Environ Hyg; 2001 May; 16(5):514-20. PubMed ID: 11370931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in identifying beryllium sensitization and disease.
    Middleton D; Kowalski P
    Int J Environ Res Public Health; 2010 Jan; 7(1):115-24. PubMed ID: 20195436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.
    Stephan CH; Sauvé S; Fournier M; Brousseau P
    J Appl Toxicol; 2009 Jan; 29(1):27-35. PubMed ID: 18785683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting borderline BeLPT results.
    Middleton DC; Mayer AS; Lewin MD; Mroz MM; Maier LA
    Am J Ind Med; 2011 Mar; 54(3):205-9. PubMed ID: 20957676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric test for beryllium sensitivity.
    Milovanova TN; Popma SH; Cherian S; Moore JS; Rossman MD
    Cytometry B Clin Cytom; 2004 Jul; 60(1):23-30. PubMed ID: 15221866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust.
    Frye BC; Quartucci C; Rakete S; Grubanovic A; Höhne K; Mangold F; Gieré R; Müller-Quernheim J; Zissel G
    Chest; 2021 Mar; 159(3):1084-1093. PubMed ID: 32926872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an abnormal beryllium lymphocyte proliferation test.
    Frome EL; Newman LS; Cragle DL; Colyer SP; Wambach PF
    Toxicology; 2003 Feb; 183(1-3):39-56. PubMed ID: 12504341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of beryllium lymphocyte proliferation testing.
    Barna BP; Culver DA; Yen-Lieberman B; Dweik RA; Thomassen MJ
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):990-4. PubMed ID: 14607857
    [No Abstract]   [Full Text] [Related]  

  • 17. Beryllium hypersensitivity and chronic beryllium lung disease.
    Santo Tomas LH
    Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey.
    Deubner DC; Goodman M; Iannuzzi J
    Appl Occup Environ Hyg; 2001 May; 16(5):521-6. PubMed ID: 11370932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
    Cher DJ; Deubner DC; Kelsh MA; Chapman PS; Ray RM
    Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.